Based on the latest data from Jun 22, 2026, MTD's PEG ratio sits at 4.47. This metric combines a PE of 27.27 with an earnings growth rate of 6.1%. Relative to the 5.31 average from the past 4 quarters, the PEG ratio fell by 16%.
Looking at the past ten years, MTD's PEG ratio has settled around 4.29 on average. At 4.47, today's PEG ratio sits 4.2% higher than its historical average. Within the past ten years, the Dec 2017 quarter saw the highest PEG reading at 47.08. At 0.71, the Dec 2018 quarter represented the lowest PEG ratio in this timeframe.
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 8.94 | 33.06 | 3.7% |
| 2024 | 2.37 | 30.09 | 12.7% |
| 2023 | N/A | 33.6 | -6.9% |
| 2022 | 2.23 | 37.26 | 16.7% |
| 2021 | 1.61 | 51.04 | 31.7% |
| 2020 | 4.3 | 45.15 | 10.5% |
| 2019 | 2.82 | 34.73 | 12.3% |
| 2018 | 0.71 | 27.82 | 39.1% |
| 2017 | 47.08 | 42.37 | 0.9% |
| 2016 | 2.12 | 28.89 | 13.6% |
| 2015 | 2.99 | 26.6 | 8.9% |
| 2014 | 1.77 | 25.83 | 14.6% |
| 2013 | 2.61 | 23.74 | 9.1% |
| 2012 | 1.89 | 20.63 | 10.9% |
| 2011 | 0.83 | 17.48 | 21.1% |
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Mar 2026 | 4.84 | 29.55 | 6.1% |
| Dec 2025 | 8.94 | 33.06 | 3.7% |
| Sep 2025 | 3.92 | 30.55 | 7.8% |
| Jun 2025 | 3.53 | 29.67 | 8.4% |
| Mar 2025 | 2.41 | 29.35 | 12.2% |
| Dec 2024 | 2.37 | 30.09 | 12.7% |
| Sep 2024 | N/A | 40.24 | -5.5% |
| Jun 2024 | N/A | 38.27 | -8.8% |
| Mar 2024 | N/A | 37.14 | -9.7% |
| Dec 2023 | N/A | 33.6 | -6.9% |
| Sep 2023 | 4.07 | 28.09 | 6.9% |
| Jun 2023 | 2.85 | 32.76 | 11.5% |
| Mar 2023 | 2.55 | 38.56 | 15.1% |
| Dec 2022 | 2.23 | 37.26 | 16.7% |
| Sep 2022 | 2.07 | 29.36 | 14.2% |
Measured against past performance, MTD's PEG ratio is above the 3, 5 and 10-year averages.
Mettler Toledo International's PEG of 4.47 is higher than the Healthcare sector and the industry average.
MTD carries a PEG ratio higher than that of peer stocks TMO and XYL.
| Stock name | PEG ratio | Market cap |
|---|---|---|
| BIO Bio-Rad Laboratories Inc | 0.45 | $7.52B |
| XYL Xylem Inc | 3.43 | $26.57B |
| TMO Thermo Fisher Scientific Inc | 3.86 | $172.44B |
| MTD Mettler Toledo International Inc | 4.47 | $23.52B |
| DHR Danaher Corp | N/A | $126.12B |
| WAT Waters Corp | N/A | $35.18B |
| BRKR Bruker Corp | N/A | $8.61B |
| HBIO Harvard Bioscience Inc | N/A | $27.31M |
MTD has a PEG ratio of 4.47, per Jun 22, 2026 data.
Across the past 3 years, MTD's PEG ratio has centered around 4.12.
Across the past 5 years, MTD's PEG ratio has centered around 2.95.
The Dec 2017 quarter marked the ten years high at 47.08 for MTD's PEG ratio.
MTD currently has a PEG ratio 4.2% above its 10-year average.
When a company's earnings growth lags its valuation, the PEG ratio tends to be elevated - as seen with MTD's 4.47 reading.
The PEG ratio derives from taking PE and dividing by the rate at which earnings are growing (YoY TTM). As of Jun 22, 2026, Mettler Toledo International carries a PE ratio of 27.27. Earnings grew at 6.1% over the TTM period ending Mar 2026. Applying the formula, this yields a PEG ratio of 4.47. PEG RATIO(4.47) = PE RATIO(27.27) / EPS GROWTH(6.1%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.